Discover the full record of transactions filed by 任永红, Director. Officer active across 1 companies, notably 艾比森. Cumulatively, 33 filings have been recorded. Regulator: AMF. The full history is accessible without signup.
Declarations 33 total
3,000 shares
SSE:273000000623256000 · 14 May 2026
34,687 shares
SSE:273000000610679300 · 13 May 2026
80,000 shares
SSE:273000000597979800 · 8 May 2026
200,000 shares
SSE:273000000588872300 · 7 May 2026
1,000 shares
SSE:273000000582979900 · 6 May 2026
617,400 shares
SSE:273000000578924580 · 30 Apr 2026
59,703 shares
SSE:273000000536783360 · 28 Apr 2026
56,210 shares
SSE:273000000524335740 · 27 Apr 2026
10,000 shares
SSE:273000000154506720 · 27 Jan 2026
8,312 shares
SSE:273000000151295300 · 26 Jan 2026
1,000 shares
SSE:273000000129081400 · 16 Jan 2026
64,500 shares
SSE:173000008997011300 · 29 May 2025
2,988 shares
SSE:173000008985683800 · 23 May 2025
16,180 shares
SSE:173000008956098200 · 15 May 2025
17,745 shares
SSE:173000008952246900 · 14 May 2025
Executives ● Purchase天 天臣医疗 7 SSE 16,000 shares
SSE:173000008516010780 · 27 Jan 2025
Ideal exit: 24 Oct 2025 (T+270) 29,004 shares
SSE:173000008214155360 · 1 Nov 2024
1,200 shares
SSE:173000008214158600 · 31 Oct 2024
2,000 shares
SSE:173000006887283900 · 31 Aug 2023
16,000 shares
SSE:173000006636984700 · 5 Jun 2023
2,000 shares
SSE:173000006628061540 · 31 May 2023
14,000 shares
SSE:173000006614201800 · 24 May 2023
7,000 shares
SSE:173000006564492400 · 4 May 2023
497,600 shares
SSE:173000005908510430 · 26 Sept 2022
374,200 shares
SZSE:173000005138469120 · 3 Dec 2021
25 of 33 declarations
Load more (8 remaining) About 任永红 Ren Yonghong is a Director at Absen. He participates in strategic decision-making and oversight of operations. His experience in the technology sector contributes to guiding the company towards innovation.